Suppr超能文献

一名服用华法林的患者出现与获得性凝血因子V抑制剂相关的出血,使用泼尼松龙成功治疗。

Bleeding associated with acquired factor V inhibitor in a patient on warfarin treated successfully with prednisolone.

作者信息

Khalafallah Alhossain, Grabek Julian, Hayes Robert, Mohamed Muhajir

机构信息

Department of Haematology, Launceston General Hospital, Tasmania, Australia.

出版信息

BMJ Case Rep. 2013 Aug 6;2013:bcr2013010018. doi: 10.1136/bcr-2013-010018.

Abstract

An 85-year-old man on warfarin for atrial fibrillation presented with skin bleeding. International normalised ratio (INR) and activated partial thromboplastin time (APTT) were elevated and did not correct even after warfarin reversal with vitamin K, prothrombin complex concentrate (PCC) and fresh frozen plasma. Mixing coagulation studies with normal plasma suggested the presence of an inhibitor rather than the multiple coagulation factor deficiencies expected with warfarin. Assays of the common-pathway coagulation factors revealed factor V concentration <2% with inhibitor level elevated to 11 Bethesda units. The bleeding resolved following a course of corticosteroids. Coagulation studies and factor V level returned to normal along with resolution of the inhibitor. We report the case of the diagnostic dilemma posed and successful therapy implemented despite the limited evidence-based data being available for the treatment of this rare condition.

摘要

一名85岁因心房颤动服用华法林的男性出现皮肤出血。国际标准化比值(INR)和活化部分凝血活酶时间(APTT)升高,即使使用维生素K、凝血酶原复合物浓缩物(PCC)和新鲜冰冻血浆逆转华法林后仍未恢复正常。与正常血浆进行的混合凝血试验提示存在抑制剂,而非华法林所致的多种凝血因子缺乏。对共同途径凝血因子的检测显示,因子V浓度<2%,抑制剂水平升高至11贝塞斯达单位。经皮质类固醇治疗后出血症状缓解。随着抑制剂的消退,凝血试验和因子V水平恢复正常。我们报告了这一病例,尽管针对这种罕见疾病的治疗缺乏足够的循证数据,但仍成功解决了诊断难题并实施了治疗。

相似文献

3
Severe bleeding caused by an inhibitor to coagulation factor V: a case report.
Blood Coagul Fibrinolysis. 1994 Feb;5(1):133-7. doi: 10.1097/00001721-199402000-00015.
4
High Titer of Acquired Factor V Inhibitor Presenting with a Pseudo-deficiency of Multiple Coagulation Factors.
Intern Med. 2018 Feb 1;57(3):393-397. doi: 10.2169/internalmedicine.9150-17. Epub 2017 Nov 1.
7
Acquired factor V inhibitor responsive to corticosteroids in a patient with double cancers.
Intern Med. 2007;46(9):621-5. doi: 10.2169/internalmedicine.46.6390. Epub 2007 May 1.
8
Acquired factor V inhibitor complicating warfarin therapy.
Am J Hematol. 2011 Aug;86(8):710-2. doi: 10.1002/ajh.22073.
9
Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
Clin Neurol Neurosurg. 2013 Jun;115(6):770-4. doi: 10.1016/j.clineuro.2012.07.006. Epub 2012 Jul 24.
10
Acquired Factor V Inhibitor with Hemorrhagic Symptoms after Prasugrel Hydrochloride Treatment.
Acta Haematol. 2020;143(5):478-480. doi: 10.1159/000502406. Epub 2019 Sep 13.

引用本文的文献

2
Acquired Factor V Inhibitors in a Patient with End-stage Renal Disease.
Intern Med. 2016;55(23):3505-3509. doi: 10.2169/internalmedicine.55.7369. Epub 2016 Dec 1.
3
Acquired Factor V Inhibitor.
Intern Med. 2016;55(20):3039-3042. doi: 10.2169/internalmedicine.55.6459. Epub 2016 Oct 15.

本文引用的文献

1
The use of rituximab therapy in patients with acquired factor V inhibitors.
Am J Hematol. 2012 Aug;87(8):826-7. doi: 10.1002/ajh.23241. Epub 2012 May 28.
2
Acquired factor V inhibitor in systemic vasculitis.
Int J Rheum Dis. 2012 Apr;15(2):e19-22. doi: 10.1111/j.1756-185X.2011.01670.x. Epub 2011 Sep 21.
3
Acquired factor V inhibitors: a systematic review.
J Thromb Thrombolysis. 2011 May;31(4):449-57. doi: 10.1007/s11239-010-0529-6.
6
Spectrum of bleeding in acquired factor V inhibitor: a summary of 33 cases.
Clin Appl Thromb Hemost. 2006 Oct;12(4):485-8. doi: 10.1177/1076029606293438.
7
Factor V inhibitors: rare or not so uncommon? A multi-laboratory investigation.
Blood Coagul Fibrinolysis. 2004 Oct;15(8):637-47. doi: 10.1097/00001721-200412000-00003.
8
Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.
Transfusion. 2002 Jan;42(1):18-26. doi: 10.1046/j.1537-2995.2002.00011.x.
9
Deep-vein thrombosis and coumarin skin necrosis associated with a factor V inhibitor with lupus-like features.
Am J Hematol. 1998 Feb;57(2):176-8. doi: 10.1002/(sici)1096-8652(199802)57:2<176::aid-ajh14>3.0.co;2-a.
10
Factor V inhibitor associated with Sjögren's syndrome.
Br J Haematol. 1995 Apr;89(4):893-6. doi: 10.1111/j.1365-2141.1995.tb08430.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验